miR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1

被引:5
|
作者
Chunxi Liu
Zhiyu Wang
Yi Wang
Wuwei Gu
机构
[1] Xi’an No.4 Hospital (The Affiliated Guangren Hospital of Xi’an Jiaotong University College Medicine),Department of Stomatology
[2] Hospital of Xi’an Jiaotong University,Department of Stomatology
来源
关键词
Oral squamous cell carcinoma; miR-338; Neuropilin1; Growth; Metastasis;
D O I
暂无
中图分类号
学科分类号
摘要
microRNAs (miRNAs) are small non-coding RNAs that have been suggested to play an essential role in tumorigenesis. Reduced expression of miR-338 has been reported in several types of cancers; however, the role of miR-338 in oral squamous cell carcinoma (OSCC) has not been elucidated. In this study, we demonstrated that miR-338 was dramatically downregulated in OSCC tissues and cell lines. Overexpression of miR-338 significantly inhibited proliferation, colony formation, migration, and invasion of OSCC cells. In addition, neuropilin1 (NRP1) was identified as a target of miR-338 in OSCC cells and inversely correlated with miR-338 in OSCC tissues. Furthermore, restoration of NRP1 attenuated the tumor-suppressive effects of miR-338. Taken together, miR-338 might inhibit growth and metastasis of OSCC cells by targeting NRP1.
引用
收藏
页码:115 / 122
页数:7
相关论文
共 50 条
  • [41] MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1
    Pan, Bin
    Zheng, Lin
    Liu, Shijie
    Fang, Jiawei
    Lou, Chao
    Hu, Xingyu
    Ye, Lin
    Lai, Hehuan
    Gao, Jiawei
    Zhang, Yejin
    Ni, Kainan
    He, Dengwei
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [42] miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP
    Jana, Samir
    Sengupta, Suman
    Biswas, Subir
    Chatterjee, Annesha
    Roy, Himansu
    Bhattacharyya, Arindam
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 482 (01) : 126 - 133
  • [43] miR-506 suppresses neuroblastoma metastasis by targeting ROCK1
    Li, Dianguo
    Cao, Yanhua
    Li, Jinliang
    Xu, Jialong
    Liu, Qian
    Sun, Xiaogang
    ONCOLOGY LETTERS, 2017, 13 (01) : 417 - 422
  • [44] Effects of miR-338 on morphine tolerance by targeting CXCR4 in a rat model of bone cancer pain
    Mei, Hong-Xia
    Zhou, Min-Hong
    Zhang, Xing-Wang
    Huang, Xi-Xi
    Wang, Yong-Le
    Wang, Pei-Fang
    Zhan, Gong-Hao
    BIOSCIENCE REPORTS, 2017, 37
  • [45] NRP1 Knockdown Inhibits The Invasion of Rhabdoid Tumor of the Kidney Cells
    Yamaoka, B.
    Nagasaki-Maeoka, E.
    Uekusa, S.
    Abe, N.
    Fujiwara, K.
    Koshinaga, T.
    Uehara, S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S238 - S239
  • [46] INDUCIBLE EXPRESSION OF NEUROPILIN-1 (Nrp1) IN HUMAN T CELLS
    Catzola, V.
    Battaglia, A.
    Buzzonetti, A.
    Monego, G.
    Bressan, A.
    Fossati, M.
    Scambia, G.
    Fattorossi, A.
    CYTOMETRY PART A, 2011, 79A (12) : 1056 - 1056
  • [47] miR-144 suppresses the growth and metastasis of laryngeal squamous cell carcinoma by targeting IRS1
    Wu, Xin
    Cui, Chang-Lei
    Chen, Wei-Lun
    Fu, Zhong-Ying
    Cui, Xiang-Yan
    Gong, Xu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (01): : 1 - 11
  • [48] miR-375 suppresses the growth and metastasis of esophageal squamous cell carcinoma by targeting PRDX1
    Wu, Kunpeng
    Liu, Feng
    Zhang, Tingting
    Zhou, Zhiliang
    Yu, Shouqiang
    Quan, Yonghui
    Zhu, Shaojin
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (05) : 2154 - 2168
  • [49] miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1
    Dang, Wei
    Qin, Zailong
    Fan, Songqing
    Wen, Qiuyuan
    Lu, Yuanjun
    Wang, Jia
    Zhang, Xuemei
    Wei, Lingyu
    He, Wei
    Ye, Qiurong
    Yan, Qun
    Li, Guiyuan
    Ma, Jian
    ONCOTARGET, 2016, 7 (22) : 32421 - 32432
  • [50] Circular RNA circGSE1 promotes angiogenesis in ageing mice by targeting the miR-323-5p/NRP1 axis
    Qiu, Jiacong
    Chen, Rencong
    Zhao, Lei
    Lian, Chong
    Liu, Zhen
    Zhu, Xiaonan
    Cui, Jin
    Wang, Siwen
    Wang, Mingshan
    Huang, Yingxiong
    Wang, Shenming
    Wang, Jinsong
    AGING-US, 2022, 14 (07): : 3049 - 3069